ID

31404

Descripción

Interleukin-1 Receptor Antagonist and Insulin Sensitivity; ODM derived from: https://clinicaltrials.gov/show/NCT00928876

Link

https://clinicaltrials.gov/show/NCT00928876

Palabras clave

Versiones (1)
  1. 19/8/18 19/8/18 -
Titular de derechos de autor

see clinicaltrials.gov

Subido en

19 de agosto de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00928876

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT00928876

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult subjects with a bmi > 30 kg/m2
Descripción

Adult | Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C1305855
3 or more characteristics of the metabolic syndrome
Descripción

Metabolic Syndrome X; Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0524620
UMLS CUI [1,2]
C1521970
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to give informed consent
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
age < 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
known diabetes mellitus
Descripción

Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
fasting plasma glucose > 7,0 mmol/l or hba1c > 6,2%
Descripción

Plasma fasting glucose measurement | Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
UMLS CUI [2]
C0019018
presence of any medical condition that might interfere with the current study protocol
Descripción

Condition; Interferes with; Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348563
immunodeficiency of immunosuppressive treatment
Descripción

Therapeutic immunosuppression; Immunologic Deficiency Syndromes

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021079
UMLS CUI [1,2]
C0021051
anti-inflammatory drugs (100 mg of aspirin/day is allowed)
Descripción

Anti-Inflammatory Agents | Aspirin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003209
UMLS CUI [2]
C0004057
signs of current infection
Descripción

Infection; Current (present time)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0521116
history of recurrent infections
Descripción

Infection; Recurrent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C2945760
pregnancy or breast feeding
Descripción

Pregnancy; Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
liver disease
Descripción

Liver diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
renal disease
Descripción

Kidney Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022658
neutropenia
Descripción

Neutropenia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027947
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00928876

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Body mass index
Item
adult subjects with a bmi > 30 kg/m2
boolean
C0001675 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Metabolic Syndrome X; Characteristics
Item
3 or more characteristics of the metabolic syndrome
boolean
C0524620 (UMLS CUI [1,1])
C1521970 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Informed consent
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus
Item
known diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Plasma fasting glucose measurement | Glycosylated hemoglobin A
Item
fasting plasma glucose > 7,0 mmol/l or hba1c > 6,2%
boolean
C0583513 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Condition; Interferes with; Study Protocol
Item
presence of any medical condition that might interfere with the current study protocol
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
Therapeutic immunosuppression; Immunologic Deficiency Syndromes
Item
immunodeficiency of immunosuppressive treatment
boolean
C0021079 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
Anti-Inflammatory Agents | Aspirin
Item
anti-inflammatory drugs (100 mg of aspirin/day is allowed)
boolean
C0003209 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
Infection; Current (present time)
Item
signs of current infection
boolean
C3714514 (UMLS CUI [1,1])
C0521116 (UMLS CUI [1,2])
Infection; Recurrent
Item
history of recurrent infections
boolean
C3714514 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
Pregnancy; Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Liver diseases
Item
liver disease
boolean
C0023895 (UMLS CUI [1])
Kidney Diseases
Item
renal disease
boolean
C0022658 (UMLS CUI [1])
Neutropenia
Item
neutropenia
boolean
C0027947 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial